In the subgroup analyses, ACLY expression was also higher in AML patients with t(11q23)/MLL abnormalities than in others such as healthy controls, AML patients with normal karyotype, t(8;21), t(15;17) and complex karyotypes, respectively. This evidence concerns the gene KMT2A and acute myeloid leukemia.